Petition to Ban the Retail Distribution Of Pure and Highly Concentrated Caffeine Sold in Powder Form as a Dietary Supplement
Submitted to the Food and Drug Administration
CSPI thus requests that FDA limit the form in which caffeine is sold to prevent unreasonable risks to adolescents and others from overdoses of caffeine.
The recent commencement of pure or highly concentrated caffeine marketing has been associated with ill effects in consumers, including deaths. CSPI thus requests that FDA limit the form in which caffeine is sold to prevent unreasonable risks to adolescents and others from overdoses of caffeine.